The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...
Queensland researchers have solved the century-old mystery of why patients who suffer severe spinal cord and brain injuries ...
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...
US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia: San Diego Monday, December 16, 2024, 16:00 Hrs [IST] ...
Corcept Therapeutics reports positive Phase 4 CATALYST results, showing Korlym significantly improves hemoglobin A1c in ...
We all have unique schedules, challenges, and responsibilities. But there’s one thing almost everyone can relate to while ...
Avoiding the hunger trap and the binge-eating cravings is difficult. Overeating or eating unhealthy foods can often derail ...
New research shows that glioblastoma has an internal clock and syncs its daily rhythms to match -- and take advantage of -- the rhythms of its host. In this way, brain tumors grow in response to the ...
Mental health challenges rarely exist in isolation. Among the most concerning combinations, dementia and depression ...
Research from Washington University shows that glioblastoma, a type of brain cancer, has its own internal clock that ...
Every purchase is backed by a 90-day refund policy. If you’re not satisfied, you can return the product hassle-free. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback